Takeda Asks 2nd Circ. To Flip Actos Rulings
Pharmaceutical firm Takeda urged the Second Circuit in a Wednesday filing to reverse two lower-court decisions that kept alive allegations claiming it delayed the entry of generic alternatives to the diabetes...To view the full article, register now.
Already a subscriber? Click here to view full article